4 recruiting, 2 completed, 1 active not recruiting, 1 not yet recruiting. 5 Phase 1, 2 Phase 2, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Recruiting 2, Active not recruiting 1, Completed 1, Terminated 1 |
| Phase 2 | 2 | Recruiting 1, Terminated 1 |
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Near Infrared Imaging: new trials by email Literature Review of Near Infrared Imaging trials Research Report on Near Infrared Imaging
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Measuring Pelvic Floor Muscle Fitness Before and After Treatment Near Infrared Imaging - Myofacial Pain, Pelvic Pain | Not applicable | Not yet recruiting | University of California, Los Angeles | 120 | 2026-09-01 | 2026-05-26 |
| Transfusion-Related Changes in Oxidative Stress Biomarkers in Neonates Peroxide analysis-TOC Omnignostica Forschungs GmbH, Near Infrared Imaging - Oxidative Stress in Neonates, Near Infrared Spectroscopy | Recruiting | Medical University of Graz | 170 | 2025-12-12 | 2026-06-26 | |
| An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors Biospecimen Collection, Near Infrared Imaging, Pafolacianine Sodium - Childhood Malignant Solid Neoplasm, Childhood Malignant Thoracic Neoplasm | Phase 3 | Recruiting | Mayo Clinic | 20 | 2025-04-15 | 2026-04-01 |
| A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery Near Infrared Imaging, Therapeutic Conventional Surgery, Tozuleristide - Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8 | Phase 1 / Phase 2 | Terminated | University of Washington | 8 | 2024-04-17 | 2026-09-16 |
| Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer Panitumumab, Indium In 111 Panitumumab, Single Photon Emission Computed Tomography - Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma | Phase 1 | Recruiting | Vanderbilt-Ingram Cancer Center | 30 | 2023-08-22 | 2026-03-05 |
| Near Infrared Technology for the Detection of Proximal Caries Near infrared imaging - Caries,Dental | Completed | Marmara University | 639 | 2022-08-08 | 2023-06-26 | |
| Bronchial NIR Image-guided Resection ICG Intervention, Near Infrared Imaging - Sentinel Lymph Node | Phase 1 / Phase 2 | Recruiting | Massachusetts General Hospital | 100 | 2015-01-06 | 2025-11-10 |
| NIR-Guided Sentinel Lymph-Node Mapping for Esophageal Cancer Near Infrared Imaging - Esophageal Cancer | Phase 1 | Completed | Dana-Farber Cancer Institute | 10 | 2013-06-21 | 2017-12-02 |
| Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer Near Infrared Imaging - Lung Cancer | Phase 1 | Active not recruiting | Dana-Farber Cancer Institute | 57 | 2009-02-18 | 2025-11-10 |
Squamous Cell Carcinoma of Head and Neck (2) · Dental Caries (1) · Esophageal Neoplasms (1) · Facial Pain (1) · Head and Neck Neoplasms (1) · Lung Neoplasms (1) · Mouth Neoplasms (1) · Pelvic Neoplasms (1) · Pelvic Pain (1) · Vaginismus (1) · beta-Thalassemia (1)
Dana-Farber Cancer Institute (2) · Marmara University (1) · Massachusetts General Hospital (1) · Mayo Clinic (1) · Medical University of Graz (1) · University of California, Los Angeles (1) · University of Washington (1) · Vanderbilt-Ingram Cancer Center (1)
United States (7) · Austria (1) · Turkey (Türkiye) (1)
Eben Rosenthal, MD (1) · Emily Marchiano (1) · Ena Suppan, MD (1) · Stephanie F. Polites, MD, MPH (1) · Yolonda Colson, MD, PhD (1) · Yolonda L Colson, MD, PhD (1) · Yolonda L. Colson, MD, PhD (1)
R61AT013008 (1)